StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2022 it was -$3.48M. The highest annual figure on record is -$3.48M in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$3.48M–
FY2021Dec 31, 2021-$24.58M–
FY2020Dec 31, 2020-$15.87M–
FY2015Dec 31, 2015-$6.38M–
FY2014Dec 31, 2014-$14.05M–
FY2013Dec 31, 2013-$12.68M–
FY2012Dec 31, 2012-$11.63M–
FY2011Dec 31, 2011-$16.36M–
FY2010Dec 31, 2010-$7.59M–

More CervoMed figures

See a number that looks wrong?